ROS HANNEN
Ros completed her BBSRC-Unilever PhD studentship in dermatoendocrinology at the Blizard Institute, Queen Mary University of London (QMUL) in 2009. She won the British Skin Foundation grant award in 2016 to further her psoriasis research and was awarded a MedCity grant (2017, the highest-ranked grant) with Fourth State Medicine to assess the effectiveness of plasma technology for chronic wound healing. In 2018 Ros won the MedTech SuperConnector and QMUL Life Sciences Initiative awards to accelerate the commercial development of her research, and most recently an Innovate UK Smart grant. Ros founded Keratify in December 2018 to advance laboratory human skin testing.